Skip to Content
Merck
CN

409731

Methyl (S)-(−)-2-isocyanato-3-phenylpropionate

99%

Sign In to View Organizational & Contract Pricing.

Select a Size

Change View

About This Item

Linear Formula:
C6H5CH2CH(NCO)CO2CH3
CAS Number:
Molecular Weight:
205.21
UNSPSC Code:
12352108
PubChem Substance ID:
MDL number:
Assay:
99%
Technical Service
Need help? Our team of experienced scientists is here for you.
Let Us Assist


assay

99%

optical activity

[α]20/D −80.0°, neat

refractive index

n20/D 1.513 (lit.)

bp

244 °C (lit.)

density

1.13 g/mL at 25 °C (lit.)

SMILES string

COC(=O)[C@H](Cc1ccccc1)N=C=O

InChI

1S/C11H11NO3/c1-15-11(14)10(12-8-13)7-9-5-3-2-4-6-9/h2-6,10H,7H2,1H3/t10-/m0/s1

InChI key

JOTMMIYKEOOTNZ-JTQLQIEISA-N

Application

This compound has been employed in the preparation of dipeptide analogs of angiotensinogen and Schiff base derivatives for the inhibition of thermolysin.


signalword

Danger

Hazard Classifications

Acute Tox. 4 Dermal - Acute Tox. 4 Inhalation - Acute Tox. 4 Oral - Eye Irrit. 2 - Flam. Liq. 3 - Resp. Sens. 1 - Skin Irrit. 2 - Skin Sens. 1 - STOT SE 3

target_organs

Respiratory system

Storage Class

3 - Flammable liquids

wgk

WGK 3

flash_point_f

116.1 °F - closed cup

flash_point_c

46.7 °C - closed cup

ppe

Eyeshields, Faceshields, Gloves, type ABEK (EN14387) respirator filter

Regulatory Information

新产品

This item has



Choose from one of the most recent versions:

Certificates of Analysis (COA)

Lot/Batch Number

Don't see the Right Version?

If you require a particular version, you can look up a specific certificate by the Lot or Batch number.

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library



Bates, S.R.E. et al.
J. Chem. Res. Synop., 48-48 (1993)
J J Plattner et al.
Journal of medicinal chemistry, 31(12), 2277-2288 (1988-12-01)
A series of renin inhibitors have been prepared and evaluated for their susceptibility to cleavage by the serine protease chymotrypsin. The compounds were designed by consideration of the structural requirements in the active-site region of renin and chymotrypsin. By systematic